Search This Blog

Friday, February 22, 2019

Teladoc view remains favorable heading into Q4 results, says Canaccord

Canaccord analyst Richard Close said his view on Teladoc remains favorable heading into its Q4 results. The analyst expects in-line to slight upside results, but warns a potential downside could be 2019 guidance because he believes current consensus may be too high on adjusted EBITDA. Close reiterated his Buy rating and $94 price target on Teladoc shares.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.